Celiac disease, typically thought of as a gastrointestinal disease, has a wide variety of symptoms that can affect other parts of the body including the mind. Many people with celiac disease report having “brain fog”, a form of cognitive impairment that can encompass disorientation, problems with staying focused and paying attention, and lapses in short-term […]
The rate of celiac disease prevalence has been steadily rising. According to a study comparing the stored blood of soldiers with people today, it has increased up to four times within the past 50 years. Looking for the reason behind such a significant rise, many papers have been published investigating possible environmental causes, including one that found a link between celiac disease and an absence of H. pylori in the stomach. Another paper, involving three of the same doctors, including Celiac Disease Foundation’s own Medical Advisory Board Member Dr. Peter Green, found another possible explanation.
A recent study, published by The American Journal of Gastroenterology has uncovered a new potential method for treating celiac disease. The study, titled “Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders” was first published online on April 8th, 2014. It’s authors, doctors and scientists hailing from all over the world, looked at several different aspects of a protein called elafin and its effect on gluten-related disorders like celiac disease.
A study recently published by The Journal of the American Medical Association has found further evidence for a link between celiac disease and irritable bowel syndrome (IBS). The study, first posted online on April 21, 2014, titled “Increased Prevalence of Celiac Disease Among Pediatric Patients With Irritable Bowel Syndrome” examined nearly a thousand Italian children […]
Compared with the general population, individuals with celiac disease were almost twice as likely to have CAD, according to a large retrospective study presented here today at the American College of Cardiology (ACC) 2014 Scientific Sessions . Even patients younger than aged 65 years were at higher risk.
A new study, with contributions made from two CDF Medical Advisory Board Members, Martin Kagnoff and Joseph A. Murray, has identified antibody biomarkers that can be potentially used to diagnose nonresponsive celiac disease.
Celiac disease, one of the most common autoimmune diseases in the world today, often goes undiagnosed due to asymptomatic patients and many nonspecific symptoms. To diagnose a patient with celiac disease, a positive intestinal biopsy is typically necessary. But when physicians need to decide on whether or not to order a biopsy, they have many […]
Alternatives to gluten are absolutely vital to those diagnosed with celiac disease as the only treatment available currently is a life-long, strict gluten-free diet. Many doctors and nutritionists recommend foods like amaranth, millet, buckwheat, and quinoa as substitutes for wheat and other grains toxic for celiac patients; however, there have been recent laboratory tests that […]
A recent study published by the American Journal of Epidemiology by several scientists including Dr. Peter H. R. Green, the founder of the Columbia University Celiac Disease Center and a Medical Advisory Board member for the Celiac Disease Foundation, has found a link between a particular bacterial strain typically found in the human gut and […]
Celiac disease (CD) is an autoimmune disease associated with small intestinal damage and villous atrophy. It occurs in genetically susceptible people of all ages and can involve a variety of symptoms and can also be asymptomatic. Not every genetically susceptible person gets CD however, most likely signifying that environmental factors influence the disease. Infant feeding […]